Major level 3 pharmaceutical drugs consumed South Korea 2022, by sales
In 2022, plain lipid modifying agents were the most consumed pharmaceutical drugs in South Korea, with a total sales value of around 1.35 trillion South Korean won. This was followed by drugs for peptic ulcers and gastroesophageal reflux disease and blood glucose lowering drugs, excluding insulin.